Open AccessP699: REAL‐LIFE OUTCOMES OF PONATINIB TREATMENT IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) OR PHILADELPHIA CHROMOSOME‐POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL): 5‐YEAR‐DATA FROM A BELGIAN REGISTRY
Author(s) -
Devos T.,
Havelange V.,
Theunissen K.,
Meers S.,
Benghiat F. S.,
Gadisseur A.,
Vanstraelen G.,
Vellemans H.,
Bailly B.,
Granacher N.,
Lewalle P.,
De Becker A.,
Van Eygen K.,
Lejeune M.,
Janssen M.,
Triffet A.,
Vrelust I.,
Deeren D.,
Mazure D.,
Beck M.,
Sebti H.,
Selleslag D.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845680.44858.4f
Subject(s) - ponatinib , medicine , dasatinib , nilotinib , myeloid leukemia , disease registry , philadelphia chromosome , pediatrics , disease , imatinib , chromosomal translocation , biochemistry , chemistry , gene